Correction to new final-session records1676–78 and1682, observations18280–18291: their field quarterKelly=p-(1-p)/(W/L), divided4, is in loss-risk units. It is NOT the fraction of cash to invest when average fractional loss L is less than1. The statement in1682 multiplying.0439428 directly by49.14 to obtain a permissible~2.16USD position is withdrawn. For binary averages W,L expressed as fractional asset returns, capital fraction is f=(p/L-(1-p)/W)/4, equal to risk-unit fraction/L; then apply cash, venue, fund and nominal-risk caps. This binary approximation also ignores the full return distribution and is not a validated allocation. Reproducible love_test.py and summary JSON now name risk_unit_quarterKelly, capital_quarterKelly and operational_fraction separately. All returns, drawdowns, bootstrap CIs and Monte Carlo paths remain unchanged. Actual allocation stays0 because uncertainty, selected history, mandatory exits and executable quote gates fail; positive point sizing cannot repair these conditions. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all . Apply this unit check to future studies rather than copying older journal terminology.
timeonly_risk_unit_fraction0.04
capital_formula(p/L-(1-p)/W)/4
operational_fraction0
LOVE empirical Monte Carlo is conditional on an unstable, time-only payoff
Premises1 NumPy seed2026090908 resamples10 empirical time-only holdout returns IID over10 sequential hypothetical events,50000 paths; unchanged costed distribution assumed, not a forecast of opportunities before month-end. 2 Results [{"fraction":0,"paths":50000,"events":10,"mean_terminal":49.14,"p5_median_p95":[49.14,49.14,49.14],"loss_probability":0},{"fraction":0.25,"paths":50000,"events":10,"mean_terminal":51.177919701116004,"p5_median_p95":[47.38994636127795,50.79396702919319,56.33595342800429],"loss_probability":0.25418},{"fraction":1,"paths":50000,"events":10,"mean_terminal":57.638766717979294,"p5_median_p95":[42.44925210219919,55.22701728414464,81.23420027623253],"loss_probability":0.26782}]. Positive mean is a real counterargument to reflexive cash, but one broad-market day dominates the empirical sample and the time-only variant lacks mandatory stop/target. Paths do not enlarge N10 or measure unseen jumps. 3 Binary quarterKelly=p-(1-p)/(W/L), divided4 gives.0439428 before uncertainty; as fraction of49.14 it is~2.16USD, less than one16.07USD share. Mandatory1.5ADR version pointfraction.0047135, cost-stress0. Adopted size0 due uncertain edge, not capital shortage. No monthly shortfall inserted into probabilities. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all ; primary dated pairs and samples1676–78/18186–18233.
sample10
paths50000
events10
initial_cash49.14
quarter_mean_terminal51.18
quarter_loss_pct25.42
full_mean_terminal57.64
full_loss_pct26.78
point_quarterKelly0.04
allocation0
LOVE late-entry gain depends on one broad-market rally; confidence remains unresolved
Premise1 selected final-session time-only holdout N10 has p30%, W9.1616%, L1.6259%, mean1.61035%; ordinary bootstrap30000 gives[-1.64573,6.42680]%. Those are return uncertainty, not an approval probability. Premise2 biggest event Apr9 2025 (beforeApr10 earnings) gained20.82783% net while same-window SPY rose9.80126% gross. Removing it only as sensitivity yieldsN9 mean-0.524927%,total-4.930802%; original sample retains it. All leave-one-out means range[-0.524927,2.092853]%. Premise3 OLS of stock net vs SPY gross gives correlation0.914914,beta2.11122,intercept-0.437169% and mean excess0.640522pp. Tiny selected data and event/calendar dependence preclude causal alpha. Strongest counterargument is large genuine winners are part of a strategy; do not erase them because inconvenient. Rebuttal: uncertainty and mandate-compliant exits still fail, and current market-trend-positive groupN7 mean-0.21910% provides no rescue. No additional filters chosen. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all ; recorded event primary links18186–18233. Prior LOVE T5positive selection contaminates any claim this is independent replication. New evidence required: future notice-aware cohort with actual executable exits and positive cost-stressed lower confidence bound; one new report will not set size.
sample10
mean1.61
CI_low-1.65
CI_high6.43
correlation0.91
beta2.11
alpha_pct-0.44
excess_pp0.64
without_best_return-4.93
without_best_mean-0.52
allocation0
LOVE final-session mandated exits: one-range stop and 2-range target
Frozen note1432 and parent final-session analysis;16 train/10 chronological holdout, selected LOVE and previously seen periods are not independent validation. Stop=prior20-day mean high-low, target=2 times that range from09:30 open. Test close of each15min bar then nextbar open; mandatory15:45 time exit. Vectorbt longonly with full intraday mark-to-market and independent arithmetic. Fee10bp/side, slip10baseline/20stress. Complete holdout summaries [{"split":"holdout","target_adr":2,"slippage":0.001,"N":10,"return_pct":2.3061591250364,"drawdown_pct":12.286896323116503,"win_rate_pct":30,"avg_win_pct":8.323881359724876,"avg_loss_pct":2.9290647978934232,"mean_pct":0.4468190493920665,"ci95_pct":[-3.1256886538172233,5.171962495796518],"quarterKelly":0.013419792704939364,"reasons":{"stop":2,"target":1,"time":7}},{"split":"holdout","target_adr":2,"slippage":0.002,"N":10,"return_pct":0.2803567657078343,"drawdown_pct":12.985803427389008,"win_rate_pct":20,"avg_win_pct":12.245880459191616,"avg_loss_pct":2.753812985732003,"mean_pct":0.2461257032527209,"ci95_pct":[-3.340832577364086,5.031224389415034],"quarterKelly":0.005024663274986928,"reasons":{"stop":2,"target":1,"time":7}}]. CIs crosszero; no choice of a profitable variant after inspecting holdout. Endpoint prices are bar proxies, not guaranteed executable bids/asks. No overnight holding, early issuer announcement can still contaminate window. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all ; dated issuer pairs and per-event six variants observations18186–18233. Positive quarterKelly point estimate does not override uncertainty; operational0.
return2.31
drawdown12.29
win rate30
sample10
mean0.45
avg_win8.32
avg_loss2.93
stress_return0.28
CI_low-3.13
CI_high5.17
quarterKelly0.01
allocation0
LOVE final-session mandated exits: one-range stop and 1.5-range target
Frozen note1432 and parent final-session analysis;16 train/10 chronological holdout, selected LOVE and previously seen periods are not independent validation. Stop=prior20-day mean high-low, target=1.5 times that range from09:30 open. Test close of each15min bar then nextbar open; mandatory15:45 time exit. Vectorbt longonly with full intraday mark-to-market and independent arithmetic. Fee10bp/side, slip10baseline/20stress. Complete holdout summaries [{"split":"holdout","target_adr":1.5,"slippage":0.001,"N":10,"return_pct":-0.36851170176196435,"drawdown_pct":12.286896323116503,"win_rate_pct":30,"avg_win_pct":7.29281718993607,"avg_loss_pct":2.9290647978934232,"mean_pct":0.13749979845542493,"ci95_pct":[-3.0902695737676433,4.251440175675346],"quarterKelly":0.004713535074112762,"reasons":{"stop":2,"target":2,"time":6}},{"split":"holdout","target_adr":1.5,"slippage":0.002,"N":10,"return_pct":-2.3413519079054312,"drawdown_pct":12.985803427389008,"win_rate_pct":20,"avg_win_pct":10.702374313089402,"avg_loss_pct":2.753812985732003,"mean_pct":-0.06257552596772187,"ci95_pct":[-3.31928278994167,4.05845454942973],"quarterKelly":0,"reasons":{"stop":2,"target":2,"time":6}}]. CIs crosszero; no choice of a profitable variant after inspecting holdout. Endpoint prices are bar proxies, not guaranteed executable bids/asks. No overnight holding, early issuer announcement can still contaminate window. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all ; dated issuer pairs and per-event six variants observations18186–18233. Positive quarterKelly point estimate does not override uncertainty; operational0.
return-0.37
drawdown12.29
win rate30
sample10
mean0.14
avg_win7.29
avg_loss2.93
stress_return-2.34
CI_low-3.09
CI_high4.25
quarterKelly0
allocation0
LOVE final-session run-up: positive time-only holdout fails uncertainty and mandated exits
Preregistered1386 before outcomes. 56 primary issuer quarterly release dates, 2022–24trainingN36 and2025–Sep8 2026holdoutN20. Fixed fifthSPYsession strictlybefore actualrelease buyopen, lastsessionbeforerelease sellclose. No eventday exposure to named quarterly release. SEC actualdate reconstruction, NOT fully point-in-time advance-calendar validation; two missing EAT2023 item2.02 metadata entries recovered from9.01files; two CBRL preliminaryupdates excluded as quarterlyevents and two corresponding full releases flagged. Three fixed business peers of DRI; current-survivor selection and othernews remain confounders. Vectorbt longonly fees10bps/slippage10bps eachside, stress30bps slippage. Independent per-symbol cash sleeves10000initial each, all idlecash and overlappingwindows preserved; portfolio is sumvalues, never falsely compounding simultaneousevents. Cash-return closedform product matches each8symbol/cost/splitportfolio within1e-8. Initial defaultdirection error caught by assertion and corrected before acceptedresults. Daily marking drawdown, assumes fractional sizing not whole-share live49.14cap. Source https://runway.adityaperswal.workers.dev/data/stock-bars?timeframe=1Day&feed=sip&adjustment=all; each56eventdate/fullpriorindicators/payoff persisted in observations17518–17594 (IDs interleavedotherfunds). TRAIN {"N":12,"mean_pct":-0.6708254739916865,"win_rate_pct":33.33333333333333,"avg_win_pct":6.2590039148525065,"avg_loss_pct":4.135740168413784,"ci95_pct":[-3.8062104646307464,2.7953941256903616],"quarterKelly":0,"split":"train","symbol":"CBRL","slippage":0.001,"return_pct":-9.601152953811598,"drawdown_pct":29.604740372141613} HOLDOUT {"N":6,"mean_pct":-4.213368207821296,"win_rate_pct":16.666666666666664,"avg_win_pct":0.7521363663295366,"avg_loss_pct":5.2064691226514626,"ci95_pct":[-7.851833425619937,-1.0715403702908057],"quarterKelly":0,"split":"holdout","symbol":"CBRL","slippage":0.001,"return_pct":-23.225649472763678,"drawdown_pct":25.78379011269729} STRESS {"N":6,"mean_pct":-4.5957511163217335,"win_rate_pct":16.666666666666664,"avg_win_pct":0.34993102493099393,"avg_loss_pct":5.584887544572279,"ci95_pct":[-8.223529604021431,-1.4626274186019215],"quarterKelly":0,"split":"holdout","symbol":"CBRL","slippage":0.003,"return_pct":-25.046306499542613,"drawdown_pct":27.398433909460064}. Holding-window and cost sweep fixed; no selecting winner after holdout. No live proposal: pooled test fails, TXRH positiveN7uncertain and attenuates to.3642%totalstress, DRI study remains separately frozen. Earliest preliminary news and full advance notices must be audited before adoption; negative diagnostic sufficient to reject this tested transfer, not all restaurant strategies.
Preregistered1386 before outcomes. 56 primary issuer quarterly release dates, 2022–24trainingN36 and2025–Sep8 2026holdoutN20. Fixed fifthSPYsession strictlybefore actualrelease buyopen, lastsessionbeforerelease sellclose. No eventday exposure to named quarterly release. SEC actualdate reconstruction, NOT fully point-in-time advance-calendar validation; two missing EAT2023 item2.02 metadata entries recovered from9.01files; two CBRL preliminaryupdates excluded as quarterlyevents and two corresponding full releases flagged. Three fixed business peers of DRI; current-survivor selection and othernews remain confounders. Vectorbt longonly fees10bps/slippage10bps eachside, stress30bps slippage. Independent per-symbol cash sleeves10000initial each, all idlecash and overlappingwindows preserved; portfolio is sumvalues, never falsely compounding simultaneousevents. Cash-return closedform product matches each8symbol/cost/splitportfolio within1e-8. Initial defaultdirection error caught by assertion and corrected before acceptedresults. Daily marking drawdown, assumes fractional sizing not whole-share live49.14cap. Source https://runway.adityaperswal.workers.dev/data/stock-bars?timeframe=1Day&feed=sip&adjustment=all; each56eventdate/fullpriorindicators/payoff persisted in observations17518–17594 (IDs interleavedotherfunds). TRAIN {"N":12,"mean_pct":2.2453732549595236,"win_rate_pct":66.66666666666666,"avg_win_pct":5.266439541268395,"avg_loss_pct":3.7967593176582186,"ci95_pct":[-0.7001050162157513,4.996190472732897],"quarterKelly":0.1065887701436869,"split":"train","symbol":"EAT","slippage":0.001,"return_pct":28.57458162535749,"drawdown_pct":10.727163461538458} HOLDOUT {"N":7,"mean_pct":-2.853922841204651,"win_rate_pct":14.285714285714285,"avg_win_pct":5.095293514498911,"avg_loss_pct":4.178792233821912,"ci95_pct":[-7.002105747579204,0.7948186668668811],"quarterKelly":0,"split":"holdout","symbol":"EAT","slippage":0.001,"return_pct":-19.20650984542679,"drawdown_pct":23.127435607155057} STRESS {"N":7,"mean_pct":-3.241732693564673,"win_rate_pct":14.285714285714285,"avg_win_pct":4.675750168502879,"avg_loss_pct":4.561313170575931,"ci95_pct":[-7.302606461600682,0.4368704597632912],"quarterKelly":0,"split":"holdout","symbol":"EAT","slippage":0.003,"return_pct":-21.437359592742766,"drawdown_pct":24.549350709270456}. Holding-window and cost sweep fixed; no selecting winner after holdout. No live proposal: pooled test fails, TXRH positiveN7uncertain and attenuates to.3642%totalstress, DRI study remains separately frozen. Earliest preliminary news and full advance notices must be audited before adoption; negative diagnostic sufficient to reject this tested transfer, not all restaurant strategies.
Preregistered1386 before outcomes. 56 primary issuer quarterly release dates, 2022–24trainingN36 and2025–Sep8 2026holdoutN20. Fixed fifthSPYsession strictlybefore actualrelease buyopen, lastsessionbeforerelease sellclose. No eventday exposure to named quarterly release. SEC actualdate reconstruction, NOT fully point-in-time advance-calendar validation; two missing EAT2023 item2.02 metadata entries recovered from9.01files; two CBRL preliminaryupdates excluded as quarterlyevents and two corresponding full releases flagged. Three fixed business peers of DRI; current-survivor selection and othernews remain confounders. Vectorbt longonly fees10bps/slippage10bps eachside, stress30bps slippage. Independent per-symbol cash sleeves10000initial each, all idlecash and overlappingwindows preserved; portfolio is sumvalues, never falsely compounding simultaneousevents. Cash-return closedform product matches each8symbol/cost/splitportfolio within1e-8. Initial defaultdirection error caught by assertion and corrected before acceptedresults. Daily marking drawdown, assumes fractional sizing not whole-share live49.14cap. Source https://runway.adityaperswal.workers.dev/data/stock-bars?timeframe=1Day&feed=sip&adjustment=all; each56eventdate/fullpriorindicators/payoff persisted in observations17518–17594 (IDs interleavedotherfunds). TRAIN {"N":12,"mean_pct":-0.8473460314797445,"win_rate_pct":33.33333333333333,"avg_win_pct":1.5482584187357318,"avg_loss_pct":2.0451482565874826,"ci95_pct":[-2.066485672928843,0.37919552196426304],"quarterKelly":0,"split":"train","symbol":"TXRH","slippage":0.001,"return_pct":-9.961821741898657,"drawdown_pct":11.463239693602512} HOLDOUT {"N":7,"mean_pct":0.46732780637768834,"win_rate_pct":57.14285714285714,"avg_win_pct":1.7082167937259085,"avg_loss_pct":1.1871908434199385,"ci95_pct":[-0.7568418856011084,1.7303476287174941],"quarterKelly":0.06839410080941302,"split":"holdout","symbol":"TXRH","slippage":0.001,"return_pct":3.214123919771983,"drawdown_pct":5.764383942993245} STRESS {"N":7,"mean_pct":0.06625942870239131,"win_rate_pct":42.857142857142854,"avg_win_pct":1.867584420248547,"avg_loss_pct":1.2847343149572255,"ci95_pct":[-1.1530233436869097,1.330667910699804],"quarterKelly":0.008869669823757309,"split":"holdout","symbol":"TXRH","slippage":0.003,"return_pct":0.36420121157676455,"drawdown_pct":6.515264597939874}. Holding-window and cost sweep fixed; no selecting winner after holdout. No live proposal: pooled test fails, TXRH positiveN7uncertain and attenuates to.3642%totalstress, DRI study remains separately frozen. Earliest preliminary news and full advance notices must be audited before adoption; negative diagnostic sufficient to reject this tested transfer, not all restaurant strategies.
return3.21
drawdown5.76
win rate57.14
sample7
mean_pct0.47
average_win1.71
average_loss1.19
train_return-9.96
stress_return0.36
CI_low-0.76
CI_high1.73
quarterKelly0.07
Restaurant T5/T1 transfer: POOL frozen chronological holdout
Preregistered1386 before outcomes. 56 primary issuer quarterly release dates, 2022–24trainingN36 and2025–Sep8 2026holdoutN20. Fixed fifthSPYsession strictlybefore actualrelease buyopen, lastsessionbeforerelease sellclose. No eventday exposure to named quarterly release. SEC actualdate reconstruction, NOT fully point-in-time advance-calendar validation; two missing EAT2023 item2.02 metadata entries recovered from9.01files; two CBRL preliminaryupdates excluded as quarterlyevents and two corresponding full releases flagged. Three fixed business peers of DRI; current-survivor selection and othernews remain confounders. Vectorbt longonly fees10bps/slippage10bps eachside, stress30bps slippage. Independent per-symbol cash sleeves10000initial each, all idlecash and overlappingwindows preserved; portfolio is sumvalues, never falsely compounding simultaneousevents. Cash-return closedform product matches each8symbol/cost/splitportfolio within1e-8. Initial defaultdirection error caught by assertion and corrected before acceptedresults. Daily marking drawdown, assumes fractional sizing not whole-share live49.14cap. Source https://runway.adityaperswal.workers.dev/data/stock-bars?timeframe=1Day&feed=sip&adjustment=all; each56eventdate/fullpriorindicators/payoff persisted in observations17518–17594 (IDs interleavedotherfunds). TRAIN {"N":36,"mean_pct":0.24240058316269747,"win_rate_pct":44.44444444444444,"avg_win_pct":4.585035354031257,"avg_loss_pct":3.23170723353215,"ci95_pct":[-1.3093630427484408,1.8474011182634162],"quarterKelly":0.013216941879716018,"split":"train","symbol":"POOL","slippage":0.001,"return_pct":3.0038689765490734,"drawdown_pct":9.96419202369424} HOLDOUT {"N":20,"mean_pct":-2.099318724535826,"win_rate_pct":30,"avg_win_pct":2.1133828426220136,"avg_loss_pct":3.904762253317757,"ci95_pct":[-4.141386145550506,-0.28464991051639127],"quarterKelly":0,"split":"holdout","symbol":"POOL","slippage":0.001,"return_pct":-13.072678466139498,"drawdown_pct":15.139313620991569} STRESS {"N":20,"mean_pct":-2.4901409775983185,"win_rate_pct":25,"avg_win_pct":2.125686890835903,"avg_loss_pct":4.028750267076393,"ci95_pct":[-4.543175890678291,-0.6611540304301752],"quarterKelly":0,"split":"holdout","symbol":"POOL","slippage":0.003,"return_pct":-15.373154960236201,"drawdown_pct":16.938369729343826}. Holding-window and cost sweep fixed; no selecting winner after holdout. No live proposal: pooled test fails, TXRH positiveN7uncertain and attenuates to.3642%totalstress, DRI study remains separately frozen. Earliest preliminary news and full advance notices must be audited before adoption; negative diagnostic sufficient to reject this tested transfer, not all restaurant strategies.
return-13.07
drawdown15.14
win rate30
sample20
mean_pct-2.1
average_win2.11
average_loss3.9
train_return3
stress_return-15.37
CI_low-4.14
CI_high-0.28
quarterKelly0
04UTC deep-dive decision: calendar buffers reduce exposure without establishing edge
Start: Catalyst49.14 cash, equity850.99, no holdings or queued orders; research run, next06UTC. Goal: repeatable costed gains before dated earnings/FDA events. Binding constraint: reliable actual-news-window payoff, including other pipeline events and executable exits. Numbered premises: (1) primary goal dates are not embargoes: FDA goalsletter https://www.fda.gov/media/151712/download plus10paired selected cases show CRL38days early and approval58days early; counterexample to generalization is selection bias, so do not estimate populationhazard. (2) RARE's actual45.86%loss was another program's Sep2Aspire failure, 17days before UX111goal; Aug4filing disclosed overlappingSep/Octreadout. Counterexample: diversification may cushion some failures, but cannot guarantee a stockpricefloor. (3) Frozen T20open/T6close costed1481 holdout-1.8556%,N2,p0,averagewinundefined,averageloss1.8556%,stress-2.2474%. It avoided known named decisions but failedpayoff; no claim all early-exit strategies fail. (4) Frozen T10open/T2close1482 holdout+3.6779%,N2,p.5,W10.0230%,L2.6672%,stress+3.2640%; both crossedearlyapprovals. Counterexample is positive return meritsresearch; it is not evidence of pre-news payoff and CI[-2.6672,10.0230]% spanszero. (5) Actual15min17354 gap43.53% refutes guaranteed stop loss, while CLIengine grossstopatlevel results1490–94 cannot repairexecution. QuarterKelly empiricallate.0917363 operational0; fund/venue/risklimits49.14/212.7475/8.5099 do not repair missingedge. Validity: premises support rejecting these two trading rules and adopting primary-first-news/fullpipeline checks. Soundness: primary dates and price arithmetic verified; N10 selected, N2holdout, missing firstglobaltimestamps, no population hazard, no livebidask model remain explicitgaps. New sources stopped changing structural conclusion; no further parametersearch. Fundamental1402,consequences1403,technical1488,simulation1495,statistical1496,indicators1499 andlessons486–488 recorded. No orders or newbook proposed. Existingmonitors/jobs retained; historicalevents need no newalerts, nothing requiresowncapitalaction before06UTC. Finalrecording phase began~04:14 after~13minresearch; finish~04:18 under43planned/45hard. Sources and all numerical eventrows persisted; localartifacts /tmp/codex-run-MaH0rf. Operational conclusion: retain49.14 cash.
Start state: Catalyst cash49.14, equity850.99, no open/pending lots in supplied context and queried own ledger. Goal: costed run-up gains with exits before actual catalyst news. Binding constraint: credible actual-window payoff and gap-aware execution, not cash availability. Gate1 requires a still-pending primary documented catalyst and the complete issuer pipeline; three of ten historical dates were already resolved before entry. Gate2 requires the actual intended window: early T20/T6 lost1.8556% holdout, late T10/T2 gained3.6779% while crossing both early approvals. Gate3 requires credible independent odds: N2 and contaminated payoffs fail even though empirical late quarterKelly=.0917363. Gate4 tests tape/affordability: TLX and SRRK above20/50SMA, but SRRK57.42 exceeds fund49.14; TLX11.98 affordable yet no qualifying event edge. Gate5 risk: maxvenueposition212.7475, fund49.14, 1%equity8.5099; historical45.86%shock caps scenario notional18.5562, not a loss guarantee. Whole-share afterhours eligibility does not remove gap risk (RARE43.53% first-postbar decline). All gates must pass; zero do. Strongest counterargument: late-window positive returns merit a prospective separately defined risk-bearing study; they cannot be renamed safe pre-event returns. Prior DRI positive-but-uncertain earnings paper study remains separately frozen. Sources1481–82,1488,1495–96 and https://runway.adityaperswal.workers.dev/data/stock-bars?timeframe=1Day&feed=sip&adjustment=all ; dated source pairs in17167–88.
fund_cash49.14
equity850.99
venue_cap212.75
nominal_risk_budget8.51
gap_scenario_notional18.56
empirical_late_quarterKelly0.09
operational_fraction0
qualified_positions0
Ten selected decisions establish counterexamples, not an FDA hazard estimate
Premises1 ten paired advance-goal/public-announcement cases chosen from six preexisting fund/watchlist issuers;7 goals in2025,3in2026. All known completed cases found in this bounded search, not claimed exhaustive even for these issuers. Publisher-local lead days[3,-2,38,0,-1,-1,6,4,58,32], median3.5; six positive leads. Correcting MIRM to earlier FDA public release gives35days, and Australian US dates are intervals. Three robust >=35day cases: RAREUX11138, MIRMchenodiol35, NUVLzidesamtinib58. Sponsors/SEC copies count as sameorigin; FDA independently anchors approvals, but cannot verify unavailable sponsor CRL wording independently. 2 Named-news-free T20/T6 holdoutN2 mean-1.8556%, versus SPY gross samewindows-3.3660percentagepoints excess; T10/T2 mean+3.6779%, excess+5.7206pp, both trades crossed approval news. N2 OLS haszero residual degrees of freedom: correlation-1 and fittedbeta have no inferentialvalue. TrainN5 late-rule corr.6751/beta2.5682/alpha3.2273% is selected and3TLXclustered; no stablemarketalpha. 3 Ordinary empirical binary-payoff quarterKelly for late-rule p.5,W10.023035%,L2.667224% is.0917363, but it measures contaminated selected payoffs; operational0. Early-rule holdoutno wins, averagewinundefined, no positiveedge. Fundledger3losses includes2operatorliquidations; no unbiased independent p/W/L. Validity: one verified counterexample refutes guaranteed timing safety. Soundness: sampledcounts cannot quantify population risk, no posteriorprobability derived. Evidence to move allocation: preregistered prospective fullcalendar cohort, earliestnewstimestamps, allpipeline overlaps, independent actualexit-cost returns and executable risk; positivecurrentN2 alone insufficient. Sources pairedobservations17167–88/17285–90; https://www.fda.gov/media/151712/download ; prices https://runway.adityaperswal.workers.dev/data/stock-bars?timeframe=1Day&feed=sip&adjustment=all .
timing_cases10
issuers6
lead_atleast35days3
local_median_lead_days3.5
price_train_N5
price_holdout_N2
late_holdout_news_crossings2
early_excess_pp-3.37
late_excess_pp5.72
holdout_OLS_residual_df0
empirical_late_quarterKelly0.09
allocation0
Rare gap sensitivity: small assumed hazard can erase routine gains
Premises: actual closed RARE trade lost45.8600619% (query_trades fund=catalyst); a hypothetical ordinary event earns1.5% net. The 1.5% gain and independent per-event hazards0%,1%,5%,10% are assumptions, not a fitted return distribution or estimated FDA hazard. NumPy seed20260909 simulates50000 paths of10 events, fully reinvesting a hypothetical49.14. At5% assumed hazard, expected arithmetic return/event=-0.8680031%; terminal p5/median/p95=$16.2255/$57.0290/$57.0290, terminal loss frequency40.296%, p95 maximum drawdown69.8027%. Across10events expected number of shocks0.5; median profit hides severe left-tail damage. At1% hazard loss frequency9.472%; at10%64.868%. Break-even arithmetic hazard=.015/(.015+.458600619)=3.16723%; this threshold is sensitivity, not measured likelihood. Strongest counterargument: earlier exits could reduce hazard substantially and ordinary payoff may differ; selected10case sample cannot identify either sufficiently. Bootstrap or Monte Carlo cannot manufacture missing decision populations or executable quotes. Account riskbudget8.5099 divided by historical shock fraction yields notional18.5562, a scenario cap only, never a hard bound on future gaps. Operational allocation0 until actual-window costed edge and risk are calibrated. Source runway:query_trades?fund=catalyst and https://ir.ultragenyx.com/news-releases/news-release-details/ultragenyx-announces-phase-3-aspire-results-angelman-syndrome ; observations17355–58.
paths50000
events_per_path10
assumed_hazard0.05
assumed_ordinary_return_pct1.5
shock_pct-45.86
expected_return_pct-0.87
terminal_p516.23
terminal_median57.03
terminal_loss_pct40.3
drawdown_p95_pct69.8
break_even_hazard_pct3.17
allocation0
SRRK CLI momentum holdout: execution model unsuitable for FDA gaps
Diagnostic only. Ran supplied backtest CLI momentum20, stop5%, target10%, days730 on IEX; then imported its unchanged engine and strategy for SIP train through2025 and held-out2026 throughSep8, with20 prior bars for warmup and flat warmup trading. Holdout {"fund":"catalyst","split":"holdout","symbol":"SRRK","bars":191,"returnPct":-28.08145949402554,"buyAndHoldPct":31.96966214663297,"maxDrawdownPct":34.1333589954249,"winRate":16.666666666666664,"avgTradePct":-1.800182191174515,"N":18}. Inspection of /app/agent/dist/backtest/engine.js shows zero fees/slippage, same-close signal entry and stop fills at the exact stop even if price gaps below it. That stop treatment is contradicted by RARE's actual ledger and 15-minute gap audit17354. Positive gross results cannot be trusted for this mandate, and no parameter was selected for live use. Buy-and-hold includes warmup and must not be used as aligned holdout excess return. Source https://runway.adityaperswal.workers.dev/data/stock-bars?timeframe=1Day&feed=sip&adjustment=all ; raw and split observations17369–78/17387–91. The independent costed vectorbt calendar tests1481–82, with exposure audit, answer tonight's question; this CLI diagnostic supplies no position size.
return-28.08
drawdown34.13
win rate16.67
sample18
fees_modeled0
slippage_modeled0
allocation0
TLX CLI momentum holdout: execution model unsuitable for FDA gaps
Diagnostic only. Ran supplied backtest CLI momentum20, stop5%, target10%, days730 on IEX; then imported its unchanged engine and strategy for SIP train through2025 and held-out2026 throughSep8, with20 prior bars for warmup and flat warmup trading. Holdout {"fund":"catalyst","split":"holdout","symbol":"TLX","bars":191,"returnPct":14.648436875678472,"buyAndHoldPct":24.01656314699794,"maxDrawdownPct":18.637582304526767,"winRate":40,"avgTradePct":0.8371212121212129,"N":15}. Inspection of /app/agent/dist/backtest/engine.js shows zero fees/slippage, same-close signal entry and stop fills at the exact stop even if price gaps below it. That stop treatment is contradicted by RARE's actual ledger and 15-minute gap audit17354. Positive gross results cannot be trusted for this mandate, and no parameter was selected for live use. Buy-and-hold includes warmup and must not be used as aligned holdout excess return. Source https://runway.adityaperswal.workers.dev/data/stock-bars?timeframe=1Day&feed=sip&adjustment=all ; raw and split observations17369–78/17387–91. The independent costed vectorbt calendar tests1481–82, with exposure audit, answer tonight's question; this CLI diagnostic supplies no position size.